Inspire Medical Systems (INSP) AGM 2026 summary

Opening remarks and agenda

• The meeting was held virtually, welcoming live questions from stockholders and introducing the board and management team members present.

Financial performance review

• Achieved $912 million in revenue for 2025, marking 14% year-over-year growth and surpassing 125,000 patients treated.

• Approaching the $1 billion revenue milestone, with continued focus on profitability and strong operating margins.

Board and executive committee updates

• Welcomed Matt Osberg as Chief Financial Officer and elevated Carlton Weatherby to Chief Strategy and Growth Officer in early 2026.

• Board and senior leadership team collaboration highlighted as key to effective oversight and strategic direction.